PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 11, 1998Archives of Internal Medicine781 citations

Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled Study

View Full Paper
SRSharon L. Rogers

Key Points

Key points are not available for this paper at this time.

Abstract

Donepezil hydrochloride (5 and 10 mg) administered once daily is a well-tolerated and efficacious agent for treating the symptoms of mild to moderately severe Alzheimer disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sharon L. Rogers (1998) studied this question.

synapsesocial.com/papers/69d8139605ee2ba81dbeef42https://doi.org/10.1001/archinte.158.9.1021
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A new rating scale for Alzheimer's disease1984 · 4,230 citations
  2. 2E2020 — The Pharmacology of a Piperidine Cholinesterase Inhibitor1991 · 88 citations
  3. 3Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?1995 · 24 citations
  4. 4“Mini-mental state”1975 · 87,447 citations
  5. 5Comprehensive Textbook of Psychiatry1967 · 3,830 citations